BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 14734483)

  • 1. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice.
    Tang XH; Knudsen B; Bemis D; Tickoo S; Gudas LJ
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):301-13. PubMed ID: 14734483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular features of tongue epithelium treated with the carcinogen 4-nitroquinoline-1-oxide and alcohol as a model for HNSCC.
    Osei-Sarfo K; Tang XH; Urvalek AM; Scognamiglio T; Gudas LJ
    Carcinogenesis; 2013 Nov; 34(11):2673-81. PubMed ID: 23784083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bitter Melon Prevents the Development of 4-NQO-Induced Oral Squamous Cell Carcinoma in an Immunocompetent Mouse Model by Modulating Immune Signaling.
    Sur S; Steele R; Aurora R; Varvares M; Schwetye KE; Ray RB
    Cancer Prev Res (Phila); 2018 Apr; 11(4):191-202. PubMed ID: 29061560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DNA methyltransferase inhibitor and all-trans retinoic acid reduce oral cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.
    Tang XH; Albert M; Scognamiglio T; Gudas LJ
    Cancer Prev Res (Phila); 2009 Dec; 2(12):1100-10. PubMed ID: 19952362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An animal model for the rapid induction of tongue neoplasms in human c-Ha-ras proto-oncogene transgenic rats by 4-nitroquinoline 1-oxide: its potential use for preclinical chemoprevention studies.
    Suzuki R; Kohno H; Suzui M; Yoshimi N; Tsuda H; Wakabayashi K; Tanaka T
    Carcinogenesis; 2006 Mar; 27(3):619-30. PubMed ID: 16219633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral-specific ablation of Klf4 disrupts epithelial terminal differentiation and increases premalignant lesions and carcinomas upon chemical carcinogenesis.
    Paparella ML; Abrigo M; Bal de Kier Joffe E; Raimondi AR
    J Oral Pathol Med; 2015 Nov; 44(10):801-9. PubMed ID: 25605610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No difference in 4-nitroquinoline induced tumorigenesis between germ-free and colonized mice.
    Zhou YX; Fuentes-Creollo G; Ponce F; Langley SA; Jen KY; Celniker SE; Mao JH; Snijders AM
    Mol Carcinog; 2019 May; 58(5):627-632. PubMed ID: 30632250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of lecithin:retinol acyltransferase in the epithelial basal layer makes mice more sensitive to oral cavity carcinogenesis induced by a carcinogen.
    Tang XH; Su D; Albert M; Scognamiglio T; Gudas LJ
    Cancer Biol Ther; 2009 Jul; 8(13):1212-3. PubMed ID: 19471114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of bexarotene and the retinoid CD1530 reduces murine oral-cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.
    Tang XH; Osei-Sarfo K; Urvalek AM; Zhang T; Scognamiglio T; Gudas LJ
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8907-12. PubMed ID: 24927566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination.
    Tanaka T; Makita H; Ohnishi M; Mori H; Satoh K; Hara A; Sumida T; Fukutani K; Tanaka T; Ogawa H
    Cancer Res; 1997 Jan; 57(2):246-52. PubMed ID: 9000563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiation of esophageal squamous cell carcinoma (ESCC) in a murine 4-nitroquinoline-1-oxide and alcohol carcinogenesis model.
    Osei-Sarfo K; Urvalek AM; Tang XH; Scognamiglio T; Gudas LJ
    Oncotarget; 2015 Mar; 6(8):6040-52. PubMed ID: 25714027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal stem cells contribute to squamous cell carcinomas in the oral cavity.
    Tang XH; Scognamiglio T; Gudas LJ
    Carcinogenesis; 2013 May; 34(5):1158-64. PubMed ID: 23358851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel rasH2 mouse carcinogenesis model that is highly susceptible to 4-NQO-induced tongue and esophageal carcinogenesis is useful for preclinical chemoprevention studies.
    Miyamoto S; Yasui Y; Kim M; Sugie S; Murakami A; Ishigamori-Suzuki R; Tanaka T
    Carcinogenesis; 2008 Feb; 29(2):418-26. PubMed ID: 18174262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by citrus auraptene in rats.
    Tanaka T; Kawabata K; Kakumoto M; Matsunaga K; Mori H; Murakami A; Kuki W; Takahashi Y; Yonei H; Satoh K; Hara A; Maeda M; Ota T; Odashima S; Koshimizu K; Ohigashi H
    Carcinogenesis; 1998 Mar; 19(3):425-31. PubMed ID: 9525276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta-carotene.
    Tanaka T; Makita H; Ohnishi M; Hirose Y; Wang A; Mori H; Satoh K; Hara A; Ogawa H
    Cancer Res; 1994 Sep; 54(17):4653-9. PubMed ID: 8062259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats.
    Fong LY; Zhang L; Jiang Y; Farber JL
    J Natl Cancer Inst; 2005 Jan; 97(1):40-50. PubMed ID: 15632379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prostaglandin E2 receptor subtype EP1-selective antagonist, ONO-8711, suppresses 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
    Makita H; Mutoh M; Maruyama T; Yonemoto K; Kobayashi A; Fujitsuka H; Toida M; Shibata T; Miyamoto S; Yasui Y; Suzuki R; Wakabayashi K; Tanaka T
    Carcinogenesis; 2007 Mar; 28(3):677-84. PubMed ID: 17052996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral carcinogenesis induced by 4-nitroquinoline 1-oxide in lecithin:retinol acyltransferase gene knockout mice.
    Liu L; Tang XH; Scognamiglio T; Gudas LJ
    J Nutr Biochem; 2010 Oct; 21(10):975-82. PubMed ID: 19954945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium.
    Wilkey JF; Buchberger G; Saucier K; Patel SM; Eisenberg E; Nakagawa H; Michaylira CZ; Rustgi AK; Mallya SM
    Mol Carcinog; 2009 Sep; 48(9):853-61. PubMed ID: 19263437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma.
    Leeman-Neill RJ; Seethala RR; Singh SV; Freilino ML; Bednash JS; Thomas SM; Panahandeh MC; Gooding WE; Joyce SC; Lingen MW; Neill DB; Grandis JR
    Cancer Prev Res (Phila); 2011 Feb; 4(2):230-7. PubMed ID: 21163936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.